|
Originally published In Press as doi:10.1074/jbc.C100767200 on June 7, 2002
J. Biol. Chem., Vol. 277, Issue 31, 28065-28069, August 2, 2002
Identification, Tissue Expression, and Functional
Characterization of Otx3, a Novel Member of the Otx Family*
Yan
Zhang ,
Takashi
Miki §,
Toshihiko
Iwanaga¶,
Yoko
Koseki ,
Masaaki
Okuno ,
Yasuhiro
Sunaga ,
Nobuaki
Ozaki ,
Hideki
Yano ,
Haruhiko
Koseki , and
Susumu
Seino **
From the Departments of Cellular and Molecular
Medicine and Molecular Embryology, Graduate School of Medicine,
and § Gene Research Center, Chiba University, Chiba
260-8670, Japan and the ¶ Laboratory of Anatomy, Graduate
School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan
Received for publication, December 30, 2001, and in revised form, May 29, 2002
 |
ABSTRACT |
Transcription factors containing a
homeodomain play an important role in the organogenesis of
vertebrates. We have isolated a novel homeodomain transcription factor,
Otx3, which is structurally and functionally related to Otx1 and Otx2,
transcription factors that are critical in brain morphogenesis. Mouse
Otx3 is a protein composed of 376 amino acids. Otx3 mRNA was
expressed in mouse embryos from 10.5 to 13.5 days postcoitum (dpc) and
in adult cerebellum as assessed by Northern blotting. Whole-mount
in situ hybridization of mouse embryos from 9.5 to 11.5 dpc
revealed strong expression of Otx3 mRNA in the diencephalon,
mesencephalon, metencephalon, myelencephalon, and developing eye,
indicating an expression pattern largely overlapping but distinct from
those of Otx1 and Otx2. In addition, Otx3 was shown by electrophoretic
mobility shift assay to bind to the TAATCC motif, the consensus binding
sequence for Otx1, Otx2, and Crx. Results of a transcription
reporter assay suggest that Otx3 functions as a transcription repressor
by binding to this motif. These results suggest that Otx3 is a novel
member of the Otx family and may be involved in the development of the central nervous system.
 |
INTRODUCTION |
Many signal molecules and transcription factors are required in
the control of induction, specification, and regionalization of the
CNS1 in vertebrates (1, 2).
Most of them have been identified as genes homologous to those in
Drosophila (1, 2) in which the patterning of the neural
primordium has been studied extensively. Among them, the Otx family
(Otx1, Otx2, and Crx), the vertebrate homologues of
orthodenticle (otd), possesses a
bicoid (Bcd)-like homeodomain and has been shown
to play an important role in brain morphogenesis in vertebrates (3).
During murine embryogenesis, Otx1 expression is detected first at the
early stage of 8.2-8.5 dpc throughout the forebrain and midbrain
neuroepithelium and in developing sense organs (4, 5). From birth day
onward, Otx1 also is expressed at a relatively low level in the
anterior lobe of the pituitary gland (6). Studies of mutant mouse
models suggest that Otx1 is involved in corticogenesis, sense organ
development, and pituitary function (3). Otx2 is expressed at an
earlier developmental stage than Otx1. In mouse, Otx2 already is
expressed before the onset of gastrulation in the epiblast and in the
visceral endoderm at 5.5 dpc (5) and also in the headfold at 7.5 dpc (4). After 8.5 dpc, the expression pattern of Otx2 largely overlaps
that of Otx1 with a posterior border at the mesencephalic side of the
isthmic constriction during brain regionalization (3, 4). Crx also was
identified as a member of the Otx family (7). The expression of
Crx is highly restricted to retina where it is profoundly involved in
differentiation and maintenance of retinal neurons. HD proteins are
thought to be involved in development and differentiation not only in
central and peripheral neurons but also in endocrine and neuroendocrine
cells (6, 8). It has been shown that many transcription factors
necessary in the development of the CNS also are involved in the
development of insulin-secreting pancreatic cells (9). We
hypothesized that known or novel HD transcription factors expressed in
pancreatic cells participate in their development by organizing the
regulated expression of the various other transcription factors.
In the present study, we have identified a novel HD transcription
factor from a pancreatic cell line that is highly expressed in
brain. It possesses a Bcd-like HD structurally and
functionally related to that of Otx1 and Otx2 and has been designated
Otx3. Our findings suggest that Otx3 may play an important role in
brain morphogenesis.
 |
EXPERIMENTAL PROCEDURES |
Screening of cDNA Library--
A partial cDNA fragment
was amplified from the mouse pancreatic cell line MIN6 by reverse
transcriptase PCR using fully degenerate primers corresponding
to the following amino acid sequences: R(S/E)RT(T/A)FT and QVWFKNR,
both of which are highly conserved among most HD proteins. The bands of
interest from the PCR were excised from a 2% agarose gel and
then subcloned and sequenced. A DNA fragment having a novel HD was
identified. This cDNA fragment was used as a probe to screen the
MIN6 cDNA library under high stringency hybridization conditions to
isolate the full-length cDNA encoding Otx3.
Northern Blot Analysis--
RNA was extracted from adult
Sprague-Dawley rat tissues and cell lines, and 20 µg of total
RNA were electrophoresed on a 1% agarose-formaldehyde gel and
transferred to a nylon membrane. The Northern blot of full stage
(4.5-18.5 dpc) mouse embryos was purchased from Seegene (Seoul,
Korea), each line containing 20 µg of total RNA. An 802-bp fragment
of Otx3 cDNA (nt 1-802), a full-length coding region of Otx1
cDNA, and a 523-bp fragment of Otx2 cDNA (nt 103-625) were
used as probes for the hybridization of Northern blots. Hybridization
was performed under standardized conditions. Membranes were washed with
0.1× SSC and 0.1% SDS at room temperature for 1 h and at
50 °C for 1 h before autoradiography.
In Situ Hybridization--
Whole-mount and section RNA in
situ hybridization was performed as described previously (10). The
cRNA probes for Otx1 and Otx2 were synthesized based on the sequences
from GenBankTM accession numbers AF424700 and P80206,
respectively. Otx1 and Otx2 cDNAs were amplified by PCR from a
mouse brain cDNA library using specific primers and subcloned into
pGEM-T easy vector (Promega, Madison, WI). For whole-mount in
situ hybridization, digoxigenin-labeled riboprobes were
synthesized using linearized DNA templates in pBluescript vector (Otx3)
(Stratagene, La Jolla, CA) and pGEM-T easy vector (Otx1 and Otx2).
Transcription reactions were carried out according to the
manufacturer's instructions using T3 (for Otx3) and SP6 (for Otx1 and
Otx2) RNA polymerase (Promega) in the presence of a digoxigenin-NTP
mixture. For in situ hybridization of Otx3 on embryo
sections, 35S-labeled riboprobes were synthesized using T3
RNA polymerase in the presence of 35S-UTP (Amersham Biosciences).
EMSA--
For EMSA, a partial Otx3 protein (aa 76-148) was
expressed as a glutathione S-transferase (GST) fusion
protein in Escherichia coli using pGEX4T-1 vector (Amersham
Biosciences) and purified by glutathione-Sepharose beads (Amersham
Biosciences). The HD-containing peptide of Otx2 (aa 34-208) was
produced using the same method. Oligonucleotide sequences used as
labeled probes in EMSA were as follows: HD consensus sequence,
5'-CAGTAAGCCTTTAATCCTGTCT-3' and its exact complement;
mutant HD consensus sequence, 5'-CAGTAAGCCAGATCTCCTGTCT-3' and its exact complement. The HD consensus sequence contains the binding sequence (TAATCC) for Otx1, Otx2, and Crx. This sequence is
disrupted in the mutant HD consensus sequence. The double-stranded probe was 32P-radiolabeled with polynucleotide kinase (New
England Biolabs, Beverly, MA). The radiolabeled probe was mixed with
in vitro translated proteins, and EMSA was performed as
described previously (11).
Transfection and Luciferase Assay--
The Otx3 expression
vector (pCMV-Otx3) and the Otx2 expression vector (pCMV-Otx2) were
generated by subcloning the entire coding region of mouse Otx3 cDNA
and partial mouse Otx2 cDNA (nt 100-867) into pcDNA3.1( )
(Invitrogen), respectively. A chimeric construct (Otx3N/Otx2C)
consisting of the N terminus of mouse Otx3 (aa 1-125) and the C
terminus of mouse Otx2 (aa 98-289) was generated and subcloned into
pcDNA3.1( ), which contains the HD domain of Otx3 and OTX-tail of
Otx2 (7). Reporter plasmid (pP3Ctk-Luc) was generated to express
luciferase under the control of thymidine kinase (tk) minimal promoter
linked to triple repeats (P3C) of the synthesized oligonucleotide
containing the consensus binding sequence (TAATCC) for the Otx family.
Neuroendocrine-derived GH3 cells were used for the transcription
reporter assay. Cells on 3.5-cm dishes were transfected with a total of
1 µg of DNA containing 250 ng of pP3Ctk-Luc and 100 ng of
pAct- -gal with or without the various Otx constructs described
above. Activity was assayed in cells transfected with 250 ng of Otx3
alone, 250 ng of Otx2 alone, 250 ng of Otx2 plus 250 ng of Otx3, or 250 ng of Otx3N/Otx2C alone. The total amount of DNA was adjusted to 1 µg
by adding empty vector DNA. Two days after transfection, the cells were harvested, and luciferase activity and -galactosidase ( -gal) activity were measured. pAct- -gal, which expresses -gal, was co-transfected to normalize transfection efficiency.
 |
RESULTS |
Otx3 Is a Novel Member of the HD Gene Family--
Since a partial
DNA fragment obtained from degenerate PCR was suggested to be a novel
transcription factor, its full-length cDNA was isolated from a
mouse MIN6 cDNA library and sequenced (Fig.
1A). Sequence analysis
revealed a novel member belonging to the HD gene family that was
designated mouse Otx3 (GenBankTM accession number
AB037698). The deduced open reading frame encodes 376 amino acids with
a predicted mass of 40 kDa. The HD of mouse Otx3 shows homology to
HD-containing transcription factors including members of the Pax, HOX,
and Pitx families. Among these, Otx3 has the highest amino acid
identity with Otx1, Otx2, and Crx (65% for each one). Further, it
possesses a lysine at the 50th amino acid residue in the HD, a feature
shared by all of the members of the Otx family, while Otx3 lacks the
so-called OTX-tail that is conserved among the other Otx members (7) (Fig. 1B). However, Otx3 lacks the other known domains,
including the paired, HOX, and POU domains present in the Pax, HOX, and Pitx families. We also have identified a human full-length Otx3 cDNA (GenBankTM accession number AB037699) from a fetal
brain cDNA library (BD Biosciences CLONTECH,
Palo Alto, CA). The amino acid identity between mouse and human Otx3 is
94.4% (data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 1.
Structures of the Otx family and Northern
blot analysis of Otx3. A, the deduced amino acid sequence of
mouse Otx3 cDNA is shown. The boxed amino acid sequence
corresponds to the HD. The lysine residue at the 50th position in the
HD is indicated by an asterisk. B, structures of
members of the Otx family. Schematic structures of Otx3, Otx1, Otx2,
and Crx are shown. Hatched, solid, and
shaded boxes indicate HD, lysine residue, and OTX-tail,
respectively. C, Otx3 mRNA expression in rat adult
tissues and endocrine cell lines. Each lane contains 20 µg of total
RNA. A single abundant transcript of 4.3 kb (indicated by an
arrow) is detected in MIN6 cells and adult cerebellum.
Skeletal m., skeletal muscle; Islets, pancreatic
islets. D, Otx3 mRNA expression during mouse
development. An arrow indicates a single transcript of about
4.3 kb from 10.5 to 13.5 dpc in mouse embryonic stages.
|
|
Expression of Otx3 mRNA in Adult Rat Tissues, Cell Lines, and
Embryos--
To examine the tissue expression pattern of Otx3, total
RNA from various adult rat tissues, endocrine cell lines, and mouse embryos at 4.5-18.5 dpc was analyzed by Northern blotting. A single abundant transcript of 4.3 kb was detected in MIN6 and adult
cerebellum, but no signal was observed in adult pancreatic islets or
the other cells and tissues (Fig. 1C). However, expression
in adult pancreatic islets was demonstrated by reverse transcriptase
PCR with Otx3-specific primers (data not shown). During embryogenesis,
the Otx3 transcript was detected from 10.5 to 13.5 dpc in mouse embryos
(Fig. 1D). To compare the expression pattern of Otx3 with
Otx1 and Otx2 during mouse development, the expression of Otx1 and Otx2
also was evaluated in the same blot (data not shown). A single Otx1
transcript of about 3.5 kb was detected from 10.5 to 15.5 dpc in mouse
embryos. Although a single Otx2 transcript of about 3.3 kb was detected from 7.5 to 18.5 dpc in mouse embryos, most abundant Otx2 mRNA was
detected from 10.5 to 13.5 dpc. The temporal expression pattern of Otx3
overlaps that of Otx1 and Otx2 during embryogenesis, especially from
10.5 to 13.5 dpc.
Spatial Expression Pattern of Otx3 in Mouse Embryos--
To
investigate Otx3 expression at early midgestational stages of mouse
development and to obtain more detailed information on the localization
of Otx3 mRNA expression in the embryos, we performed whole-mount
in situ hybridization of mouse embryos from 8.5 to 11.5 dpc
(Fig. 2A, A1-A3).
For comparison, whole-mount in situ hybridization of Otx2
(Fig. 2A, A4-A6) and Otx1 (Fig. 2A,
A7-A9) also were performed in mouse embryos from 9.5 to
11.5 dpc. At 8.5 dpc, Otx3 transcripts were detected in the prospective midbrain region and preoptic placode (data not shown). From 9.5 to 11.5 dpc, Otx3 expression was craniocaudally delimited to the rostral region
of the developing nervous system (Fig. 2A,
A1-A3). In 9.5 dpc embryos, the anterior and posterior
boundaries of Otx3 expression coincide with those of the diencephalon
and mesencephalon, respectively (Fig. 2A, A1).
Beginning from 10.5 dpc, Otx3 expression progressively declines in the
anterior region, and the most intense hybridization signal coincides
with the midbrain-hindbrain boundary (Fig. 2A,
A2, arrowhead). In addition, Otx3 expression was
observed in the developing eye (Fig. 2A, A2 and
A3). At 11.5 dpc, Otx3 expression is enhanced gradually in a
craniocaudal direction within the mesencephalon, metencephalon, and
myelencephalon (Fig. 2A, A3).

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 2.
In situ hybridization analyses of
mouse embryos. A, whole-mount in situ
hybridization. Expression of Otx3 (A1-A3), Otx2
(A4-A6), and Otx1 (A7-A9) in 9.5 dpc
(A1, A4, and A7), 10.5 dpc
(A2, A5, and A8), and 11.5 dpc
(A3, A6, and A9) mouse embryos. An
arrowhead indicates the midbrain-hindbrain boundary.
A10-A12, expression patterns of Otx1 (yellow),
Otx2 (red), and Otx3 (blue) in the developing CNS
at 9.5, 10.5, and 11.5 dpc mouse embryos. Te, telencephalon;
Di, diencephalon; Ms, mesencephalon;
Mt, metencephalon; My, myelencephalon;
Oc, optic cups. B, in situ
hybridization in sections: Otx3 expression of mesencephalon in
transverse sections at 10.5 dpc (B1 and B2) and
sagittal sections of whole-mount mouse embryos at 13.5 dpc
(B3 and B4). The bright field image shown
in B2 corresponds to the dark field image shown in
B1. B4 is a higher magnification of the
boxed region in B3. Scale bar, 200 µm.
|
|
To investigate Otx3 expression along the dorsoventral axis, we
performed in situ hybridization on transverse sections
through the mesencephalon of 10.5 dpc embryos and found that Otx3 is
expressed, but not in the floor plate (Fig. 2B,
B1 and B2). In 13.5 dpc embryos, Otx3 expression
is present in the mesencephalon and extends posteriorly to regions of
the metencephalon and myelencephalon as shown in sagittal sections
(Fig. 2B, B3 and B4). Similarly to
Otx3, Otx1 and Otx2 are expressed in the restricted regions of the
developing forebrain and midbrain in early midgestation of mouse
embryos as reported previously (3). In 9.5 dpc embryos, Otx1 is
expressed intensely in the telencephalon, diencephalon, mesencephalon,
and optic vesicles (Fig. 2A, A7). Otx2 is
expressed in the telencephalon, diencephalon, and mesencephalon as well
as in optic vesicles at 9.5 dpc (Fig. 2A, A4). At
10.5 dpc, Otx1 expression is still seen in the telencephalon,
diencephalon, mesencephalon, and optic cups as in 9.5 dpc embryos (Fig.
2A, A8). Otx2 expression is observed in the
diencephalon, mesencephalon, and optic cups as is Otx3, but Otx2 is
only barely visible in the telencephalon at 10.5 dpc (Fig.
2A, A5). In 11.5 dpc embryos, Otx1 is expressed
in the telencephalon as well as the diencephalon, mesencephalon, and
developing eye (Fig. 2A, A9), while Otx2
expression is restricted to the mesencephalon and optic cups (Fig.
2A, A6). The expression patterns of Otx3, Otx2,
and Otx1 are schematically summarized by a line diagram in Fig.
2A, A10 (9.5 dpc), A11 (10.5 dpc), and
A12 (11.5 dpc). All three genes are expressed in the
mesencephalon and diencephalon throughout these stages, while only Otx3
is expressed in the metencephalon and myelencephalon at 11.5 dpc.
DNA Binding Activity of Otx3 Protein--
The Otx family has
lysine at the 50th position of the HD, which confers DNA binding
specificity for the sequence motif TAATC(C/T) (the consensus for Otx1
and Otx2) or TAATC(C/A) (the consensus for Crx) (5, 7, 12). The
binding of Otx3 to the motif TAATCC was tested using EMSA. A fusion
protein of GST and the HD of Otx3 was incubated with radiolabeled DNA
probes. Otx3 HD showed strong binding to the HD consensus sequence in
Fig. 3A, lane 3.
Fusion protein GST-Otx2 was used as a positive control. Specificity of
Otx3 binding to the HD consensus sequence was examined by a competition
experiment. The excess amount of unlabeled competitor of the HD
consensus sequence resulted in a remarkable inhibition of the DNA
binding activity of Otx3. However, binding was not inhibited by
competition with the mutant HD consensus sequence (Fig.
3B).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
EMSA (A and
B) and transcriptional analysis (C)
of Otx3 protein in GH3 cells. A, in lane 1,
radiolabeled oligonucleotide probes were incubated without the protein.
In lane 2, radiolabeled oligonucleotide probes were
incubated with GST-Otx2 fusion protein. In lane 3,
radiolabeled oligonucleotide probes were incubated with GST-Otx3 fusion
protein. The arrow indicates a shifted band. B,
the unlabeled HD consensus sequence (TAATCC) was co-incubated as a
competitor at increasing molar excess relative to the labeled probe in
lanes 2-5 (1-, 10-, 20-, and 30-fold molar excess in
lanes 2-5, respectively). The mutant HD consensus sequence
was included as a competitor at increasing molar excess relative to the
labeled probe in lanes 6-9 (1-, 10-, 20-, and 30-fold molar
excess in lanes 6-9, respectively). C, relative
luciferase activity of Otx3, Otx2, Otx2 plus Otx3, and Otx3N/Otx2C.
Values are expressed as percentage relative to basal level (100%).
Results were obtained from four independent experiments
(n = 13-18). The single asterisk (*)
indicates luciferase activity that is significantly different from the
basal level (p < 0.0001). The double
asterisk (**) shows the statistical significance (p < 0.001) as indicated.
|
|
Transcriptional Activity of Otx3--
To assay the activity of
Otx3 as a transcription factor, a transcription reporter assay was
performed in the neuroendocrine cell line GH3. Co-transfection of the
cells with pP3Ctk-Luc and pCMV-Otx2 stimulated luciferase activity to
29-fold the activity in cells transfected with pP3Ctk-Luc alone (basal
activity). When the cells were co-transfected with pP3Ctk-Luc and
pCMV-Otx3, luciferase expression was suppressed to 36.6 ± 5.7%
of the basal level (Fig. 3C). When the cells were
co-transfected with pCMV-Otx3 and pCMV-Otx2 at a 1:1 ratio, reporter
activity was suppressed to one-third the activity from Otx2 alone. This
suggests that Otx3 functions as a transcription repressor of the Otx2
by acting competitively on the consensus sequence. We also generated a
chimeric construct consisting of Otx3 and Otx2, in which the C
terminus of Otx3 is replaced with that of Otx2. This replacement
results in the reversion of Otx3 to an activator (438.6 ± 63.1%)
from a repressor (36.6 ± 5.7%).
 |
DISCUSSION |
We have identified a novel transcription factor, Otx3. Otx3
contains a Bcd-like HD that is conserved among HD proteins,
including the Drosophila anterior morphogen Bcd
(13), otd (14), and its vertebrate homologues, the Otx
family (Otx1, Otx2, and Crx) (5, 7), Goosecoid
(Gsc) (15, 16), and vertebrate Ptx1 (17). The sequence
similarities between Otx3 and Otx1, Otx2, and Crx indicate that Otx3 is
structurally related to these members of the Otx family. In addition,
the conservation of lysine in HD also suggests that Otx3 is a member of
the Otx family. We examined mRNA expression of Otx3 by Northern
blot analysis of adult tissues and clonal cell lines and found that
Otx3 was most abundantly expressed in brain rather than in the
endocrine pancreas. Temporal and spatial expression patterns of Otx3
during embryogenesis were further investigated in mouse embryos by
Northern blotting and whole-mount in situ analyses. During
embryogenesis, Otx3 mRNA expression was detected first at day 8.5 dpc and was most abundant from 9.5 to 11.5 dpc. During this
developmental period, Otx1 and Otx2 have been shown to be expressed and
to participate in brain morphogenesis (3). Whole-mount in
situ hybridization was performed at different embryonic stages
from 8.5 to 11.5 dpc. At day 8.5 dpc, Otx3 was expressed in the
prospective midbrain region and preoptic placode. At day 9.5-11.5 dpc,
the high level expression of Otx3 in the head became restricted to the
diencephalon, mesencephalon, and developing eye, although it was also
expressed in the metencephalon and myelencephalon. The spatial
expression pattern of Otx3 during mouse embryogenesis largely
overlapped that of Otx1 and Otx2. Otx1 and Otx2 are thought to
cooperate in brain morphogenesis (18); studies of knockout mice
(Otx1 / Otx2+/ mice
(19) and Otx1+/ Otx2+/
mice (20)) indicate that the Otx gene dosage is critical in correct
positioning of the isthmic organizer. At this midbrain-hindbrain boundary, Otx3 expression showed the most intense hybridization signal
during brain developmental stages. This finding suggests that Otx3
together with Otx1 or Otx2 may be involved in positioning in this area.
Since the resemblance in the expression patterns of Otx3, Otx1, and
Otx2 should reflect their functional similarities, we examined the DNA
binding properties and the transcriptional activity of Otx3. As
previously reported, lysine at position 50 in the HD is critical for
DNA binding; the substitution of the lysine of the Bcd with
glutamine has been shown to result in the loss of DNA binding
specificity (12). Because all of these HD proteins recognize the same
binding sites with high specificity (12, 21), we assumed that Otx3
would bind to the consensus sequences of Bcd-like HD
proteins by interaction with the HD domain of Otx3. Indeed EMSA
revealed that Otx3 specifically binds to the consensus sequence TAATCC.
In addition, EMSA showed that Otx3 also binds to TAATCA, the consensus
sequence for Crx (data not shown). We next determined whether or not
Otx3 acts as a transcription factor using a luciferase reporter assay
in GH3 cells. Otx3 was shown to act as a transcription factor by
binding to the TAATCC sequence. The result of the luciferase reporter
assay showed that Otx3 represses the transcription activity triggered
by the tk minimal promoter. In addition, the reporter assay of the
co-transfection experiments with Otx3 and Otx2 showed that Otx3
significantly suppressed Otx2-induced transcription activity,
suggesting that Otx3 functions as a transcription repressor of Otx2 by
acting competitively on the target sequence. Interestingly Otx3 lacks the "OTX-tail," a conserved motif of about 20 amino acids that is
generally believed to confer transactivation activity in the Otx family
(7, 22). In addition, the motif contains an alanine-rich region in the
C terminus that is similar to the repression domain in some
Drosophila transcription repressors, including
Gsc (15, 16), Engrailed (En),
Eve, and kruppel (kr) (23), and may be an important feature of repressor proteins (23). In each case, the
repressor domain consists of at least 26% alanine residues, while 33%
of the residues of the alanine-rich domain were alanine in Otx3. In
addition, replacing the C terminus of Otx3 with that of Otx2 changed
the transcriptional character of Otx3 from repressor to activator.
Together these findings suggest that the C terminus of Otx3 acts as a
transcription repressor, but further experiments are required to
establish that Otx3 functions as a repressor of brain function.
It should be noted that the spatial and temporal expression patterns of
Otx3, Otx1, and Otx2 are similar but not identical. At 9.5 dpc, Otx3
was not expressed in telencephalon, while both Otx1 and Otx2 were
expressed in this area. At 10.5 and 11.5 dpc, the expression pattern of
Otx3 resembled that of Otx2 but not Otx1 as assessed by whole-mount
in situ hybridization. Analysis of in situ
hybridization in sections at 13.5 dpc showed that the expression
pattern of Otx3 in the myelencephalon was distinct from those of Otx1
and Otx2. Thus, Otx3 expression is craniocaudally more restricted than
Otx1 and Otx2. Furthermore, the phenotypes of Otx1
(Otx1 / ) and Otx2
(Otx2 / ) knockout mice are different:
Otx2 / mice lack forebrain and midbrain,
which is embryonically lethal (24, 25);
Otx1 / mice are viable but exhibit epilepsy,
transient dwarfism, transient hypogonadism, and abnormality in inner
ear and eyes (6, 26). Accordingly, although Otx3 is likely involved in
brain morphogenesis in concert with Otx1 and Otx2, it may have a
functionally distinct role from that Otx1 and Otx2.
 |
FOOTNOTES |
*
This work was supported by grants-in-aid for creative
scientific research and for scientific research from the Ministry of Education, Culture, Sports, Science and Technology; by a scientific research grant from the Ministry of Health, Labor and Welfare, Japan;
by grants from Novo Nordisk Pharma Ltd. and from Takeda Chemical
Industries Ltd.; and by the Yamanouchi Foundation for Research on
Metabolic Disorders.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB037698 and AB037699.
**
To whom correspondence should be addressed. Tel.: 81-43-226-2187;
Fax: 81-43-221-7803; E-mail: seino@med.m.chiba-u.ac.jp.
Published, JBC Papers in Press, June 7, 2002, DOI 10.1074/jbc.C100767200
 |
ABBREVIATIONS |
The abbreviations used are:
CNS, central nervous
system;
HD, homeodomain;
dpc, days postcoitum;
EMSA, electrophoretic
mobility shift assay;
otd, orthodenticle;
Bcd, bicoid;
tk, thymidine kinase;
Gsc, Goosecoid;
En, Engrailed;
kr, krupple, nt,
nucleotides;
aa, amino acids;
GST, glutathione
S-transferase;
-gal, -galactosidase.
 |
REFERENCES |
| 1.
|
Lemaire, P.,
and Kodjabachian, L.
(1996)
Trends. Genet.
12,
525-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Tam, P. P.,
and Behringer, R. R.
(1997)
Mech. Dev.
68,
3-25[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Acampora, D.,
Gulisano, M.,
Broccoli, V.,
and Simeone, A.
(2001)
Prog. Neurobiol.
64,
69-95[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Simeone, A.,
Acampora, D.,
Gulisano, M.,
Stornaiuolo, A.,
and Boncinelli, E.
(1992)
Nature
358,
687-690[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Simeone, A.,
Acampora, D.,
Mallamaci, A.,
Stornaiuolo, A.,
D'Apice, M. R.,
Nigro, V.,
and Boncinelli, E.
(1993)
EMBO J.
12,
2735-2747[Medline]
[Order article via Infotrieve]
|
| 6.
|
Acampora, D.,
Mazan, S.,
Tuorto, F.,
Avantaggiato, V.,
Tremblay, J. J.,
Lazzaro, D.,
di Carlo, A.,
Mariano, A.,
Macchia, P. E.,
Corte, G.,
Macchia, V.,
Drouin, J.,
Brulet, P.,
and Simeone, A.
(1998)
Development
125,
1229-1239[Abstract]
|
| 7.
|
Furukawa, T.,
Morrow, E. M.,
and Cepko, C. L.
(1997)
Cell
91,
531-541[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Szeto, D. P.,
Rodriguez-Esteban, C.,
Ryan, A. K.,
O'Connell, S. M.,
Liu, F.,
Kioussi, C.,
Gleiberman, A. S.,
Izpisua-Belmonte, J. C.,
and Rosenfeld, M. G.
(1999)
Genes Dev.
13,
484-494[Abstract/Free Full Text]
|
| 9.
|
Edlund, H.
(1998)
Diabetes
47,
1817-1823[Abstract]
|
| 10.
|
Akasaka, T.,
van Lohuizen, M.,
van der Lugt, N.,
Mizutani-Koseki, Y.,
Kanno, M.,
Taniguchi, M.,
Vidal, M.,
Alkema, M.,
Berns, A.,
and Koseki, H.
(2001)
Development
128,
1587-1597[Abstract]
|
| 11.
|
Wilson, D.,
Sheng, G.,
Lecuit, T.,
Dostatni, N.,
and Desplan, C.
(1993)
Genes Dev.
7,
2120-2134[Abstract/Free Full Text]
|
| 12.
|
Treisman, J.,
Gonczy, P.,
Vashishtha, M.,
Harris, E.,
and Desplan, C.
(1989)
Cell
59,
553-562[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Berleth, T.,
Burri, M.,
Thoma, G.,
Bopp, D.,
Richstein, S.,
Frigerio, G.,
Noll, M.,
and Nusslein-Volhard, C.
(1988)
EMBO J.
7,
1749-1756[Medline]
[Order article via Infotrieve]
|
| 14.
|
Finkelstein, R.,
Smouse, D.,
Capaci, T. M.,
Spradling, A. C.,
and Perrimon, N.
(1990)
Genes Dev.
4,
1516-1527[Abstract/Free Full Text]
|
| 15.
|
Mailhos, C.,
Andre, S.,
Mollereau, B.,
Goriely, A.,
Hemmati-Brivanlou, A.,
and Desplan, C.
(1998)
Development
125,
937-947[Abstract]
|
| 16.
|
Goriely, A.,
Stella, M.,
Coffinier, C.,
Kessler, D.,
Mailhos, C.,
Dessain, S.,
and Desplan, C.
(1996)
Development
122,
1641-1650[Abstract]
|
| 17.
|
Lamonerie, T.,
Tremblay, J. J.,
Lanctot, C.,
Therrien, M.,
Gauthier, Y.,
and Drouin, J.
(1996)
Genes Dev.
10,
1284-1295[Abstract/Free Full Text]
|
| 18.
|
Suda, Y.,
Matsuo, I.,
and Aizawa, S.
(1997)
Mech. Dev.
69,
125-141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Acampora, D.,
Avantaggiato, V.,
Tuorto, F.,
and Simeone, A.
(1997)
Development
124,
3639-3650[Abstract]
|
| 20.
|
Suda, Y.,
Nakabayashi, J.,
Matsuo, I.,
and Aizawa, S.
(1999)
Development
126,
743-757[Abstract]
|
| 21.
|
Hanes, S. D.,
and Brent, R.
(1989)
Cell
57,
1275-1283[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Chau, K. Y.,
Chen, S.,
Zack, D. J.,
and Ono, S. J.
(2000)
J. Biol. Chem.
275,
37264-37270[Abstract/Free Full Text]
|
| 23.
|
Han, K.,
and Manley, J. L.
(1993)
EMBO J.
12,
2723-2733[Medline]
[Order article via Infotrieve]
|
| 24.
|
Acampora, D.,
Mazan, S.,
Lallemand, Y.,
Avantaggiato, V.,
Maury, M.,
Simeone, A.,
and Brulet, P.
(1995)
Development
121,
3279-3290[Abstract]
|
| 25.
|
Matsuo, I.,
Kuratani, S.,
Kimura, C.,
Takeda, N.,
and Aizawa, S.
(1995)
Genes Dev.
9,
2646-2658[Abstract/Free Full Text]
|
| 26.
|
Acampora, D.,
Mazan, S.,
Avantaggiato, V.,
Barone, P.,
Tuorto, F.,
Lallemand, Y.,
Brulet, P.,
and Simeone, A.
(1996)
Nat. Genet.
14,
218-222[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Seino, T. Miki, H. Kiyonari, T. Abe, W. Fujimoto, K. Kimura, A. Takeuchi, Y. Takahashi, Y. Oiso, T. Iwanaga, et al.
Isx Participates in the Maintenance of Vitamin A Metabolism by Regulation of {beta}-Carotene 15,15'-Monooxygenase (Bcmo1) Expression
J. Biol. Chem.,
February 22, 2008;
283(8):
4905 - 4911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Fujimoto, T. Shiuchi, T. Miki, Y. Minokoshi, Y. Takahashi, A. Takeuchi, K. Kimura, M. Saito, T. Iwanaga, and S. Seino
Dmbx1 is essential in agouti-related protein action
PNAS,
September 25, 2007;
104(39):
15514 - 15519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takahashi and P. W. H. Holland
Amphioxus and ascidian Dmbx homeobox genes give clues to the vertebrate origins of midbrain development
Development,
July 15, 2004;
131(14):
3285 - 3294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Levantini, A. Giorgetti, F. Cerisoli, E. Traggiai, A. Guidi, R. Martin, D. Acampora, P. D. Aplan, G. Keller, A. Simeone, et al.
Unsuspected role of the brain morphogenetic gene Otx1 in hematopoiesis
PNAS,
September 2, 2003;
100(18):
10299 - 10303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Viczian, R. Vignali, M. E. Zuber, G. Barsacchi, and W. A. Harris
XOtx5b and XOtx2 regulate photoreceptor and bipolar fates in the Xenopus retina
Development,
April 1, 2003;
130(7):
1281 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|